Crispr Therapeutics Ag (CRSP)

Other Income/Expenses (Net)

$83.76M

TTM · Period ending: · USD

CRSP logo

CRSP Other Income/Expenses (Net)

Latest reported$83.76M
CRSP TTM Other Income/Expenses (Net) (-$92.00K → $83.76M)
High-resolution chart · PNG

CRSP other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
83,760,000
-15,028,000
-9,647,000
-6,435,000
-7,608,000
92,717,000
103,900,000
95,920,000
91,527,000
83,794,000
71,816,000
63,309,000
49,902,000
35,040,000
22,661,000
17,873,999
11,710,999
8,916,999
10,508,999
4,674,999
3,733,999
4,395,999
6,672,999
25,367,000
24,741,000
24,698,000
20,566,000
-1,125,000
-1,801,000
-4,168,000
-5,485,000
-3,769,000
-3,057,000
-2,725,000
-1,960,000
41,260,000
41,614,000
41,674,000
45,412,000
2,554,000
2,631,000
3,265,000
-92,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.